Professional Documents
Culture Documents
Objectives
Aetiological factors Risk factors Pathophysiology Clinical presentation Investigations Prophylaxis Treatment options
DEFINITION
Formation of a semi-solid coagulum within flowing blood in the venous system
DVT EPIDEMIOLOGY
Annual incidence 1/1000 Accounts for over one half of VTE Up to 80% of patients with VTE have one or more risk factors Majority of lower extremity DVT arise from calf veins but ~20% begin in proximal veins About 20% of calf-limited DVTs will propagate proximally
AETIOLOGY
Virchows triad
Endothelial damage Stasis Coagulability
RISK FACTORS
Malignancy Surgery Trauma Pregnancy
CLINICAL PRESENTATION
CLASSICAL SIGNS
calf pain Tenderness Swelling redness Homans sign
Overall sensitivity/specificity = 3-91% Unreliable for diagnostic decisions Up to 50% have none of these Wells developed and tested a clinical prediction model for DVT
CASE
37 years old moderately obese female on OCP presents to you with a two day history of painless R leg swelling. Shes been elevating her leg several days after a severe ankle sprain during playing with her daughter
No prior medical history, recent surgery or weight loss. Exam is notable for R ankle splint and pitting edema in R calf, which is 1.5 cm larger than the L.
DVT Case
Our patient has 2-3 risk factors
OCP, +/- immobilization and trauma
Her Wells score gives her a moderate pretest probability for DVT A d-dimer test is performed
INVESTIGATIONS
D-Dimer
Fibrin degradation product elevated in active thrombosis Negative test can help exclude VTE Less helpful in malignancy and recent surgery
D-Dimer
In 283 patients with suspected DVT, lowmoderate Wells DVT score and negative ddimer only 1 (NPV 99.6%) had DVT over next 3 months
Sensitive d-dimer testing can rule out DVT in lowmoderate risk patients
DVT Case
D-dimer performed is postitive in our patient Unfortunately a positive ddimer is not helpful diagnostically An imaging study is done
IMAGING
Compression US :
first line test, high sens/spec
Venography
gold standard
MRI
Lower quality evidence only at present
DVT Case
Compression US negative Options include:
Venography or MRI Serial compression US single US done at 5-7 days reliably excludes calf-limited DVT Follow clinically for resolution of symptoms riskier, no data supporting safety of this option
Thrombophilia screening Factor V leiden, Prot C/S deficiency, Antithrombin III deficiency
Idiopathic DVT < 50 years Family history of DVT Thrombosis in an unusual site Recurrent DVT
CASE
The patient in Case 1 elected to be followed clinically. She returned to clinic 3 days later with persistent swelling, but no new symptoms She was to return the following week, but instead you are called to the ER 10 days later after she presents with acute onset of dyspnea and pleuritic chest pain
PE Clinical Presentation
Dyspnea, pleuritic pain and cough most common symptoms Tachypnea, rales and tachycardia most common signs ABG, EKG and CXR
May be abnormal Lack specificity to aid diagnosis
PIOPED Study. JAMA. 1990;263(20):2753-59. Stein PD, Goldhaber SZ, Henry JW. Chest 1995;107:139-43
PE Case 2
Findings in the ER
Alert white female, mildly anxious T 101, HR 105, RR 18 R LE edema and redness Lungs clear to auscultation ABG mild respiratory alkalosis; aA gradient = 17 CXR showing mild atelectasis
PE Case 2
High risk for PE by Modified Wells Criteria (Wells score = 9) Positive D-dimer, but negative test would not have safely excluded PE Options include:
CT angiogram V/Q scan Lower extremity compression US
PE Imaging Studies
V/Q scans in diagnosing PE
Drawbacks: more difficult test and 73% patients had indeterminate scans
LE compression US
Finding of a DVT completes workup Negative study insufficient to exclude VTE
PE Case 2
MDCT segmental embolus Therapy
Enoxaparin 1mg/kg sq every 12 hours for 5 days Warfarin started day 1 at 5 mg a day CBC on day 3-5 and INR every day if inpatient May stop enoxaparin after 5 days if INR > 2.0 Warfarin continued to keep INR at 2.5 (2.0-3.0 range) for 3 months
MANAGEMENT
Enoxaparin 1mg/kg sc every 12 hours for 5 days Warfarin started day 1 at 5 mg a day CBC on day 3-5 and INR every day if inpatient May stop enoxaparin after 5 days if INR > 2.0 Warfarin continued to keep INR at 2.5 (2.0-3.0 range) for 3 months
OPTIONS
Low dose unfractionated heparin or LMWH Sequential compression devices Graduated compression stockings